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Abstract
The recognition of sialic acids by two strains of minute virus of mice (MVM), MVMp (prototype) and MVMi
(immunosuppressive), is an essential requirement for successful infection. To understand the potential for recognition of
different modifications of sialic acid by MVM, three types of capsids, virus-like particles, wild type empty (no DNA) capsids,
and DNA packaged virions, were screened on a sialylated glycan microarray (SGM). Both viruses demonstrated a preference
for binding to 9-O-methylated sialic acid derivatives, while MVMp showed additional binding to 9-O-acetylated and 9-O-
lactoylated sialic acid derivatives, indicating recognition differences. The glycans recognized contained a type-2 Galb1-
4GlcNAc motif (Neu5Aca2-3Galb1-4GlcNAc or 39SIA-LN) and were biantennary complex-type N-glycans with the exception
of one. To correlate the recognition of the 39SIA-LN glycan motif as well as the biantennary structures to their natural
expression in cell lines permissive for MVMp, MVMi, or both strains, the N- and O-glycans, and polar glycolipids present in
three cell lines used for in vitro studies, A9 fibroblasts, EL4 T lymphocytes, and the SV40 transformed NB324K cells, were
analyzed by MALDI-TOF/TOF mass spectrometry. The cells showed an abundance of the sialylated glycan motifs recognized
by the viruses in the SGM and previous glycan microarrays supporting their role in cellular recognition by MVM.
Significantly, the NB324K showed fucosylation at the non-reducing end of their biantennary glycans, suggesting that
recognition of these cells is possibly mediated by the Lewis X motif as in 39SIA-LeX identified in a previous glycan microarray
screen.
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Introduction
Viruses serve as robust genome delivery vehicles evolved to
utilize an array of intricate strategies for successful infection of
target host organisms. The key initial step is virus attachment to
cell surface receptors, followed by internalization into the cytosol,
targeting, and release of the viral genome to the replication
compartment. Proteins, carbohydrates, and lipids constitute
receptors for many enveloped and non-enveloped viruses. Some
serve as ‘attachment factors’ that concentrate virus on the cell
surface and stimulate it to bind to secondary receptors or co-
receptors that guide virus entry into cells. Glycans (complex
carbohydrates) are the major constituents of the cell surface and
may be conjugated to proteins or membrane lipid head groups to
form glycoproteins and glycolipids, respectively, or are present as
glycosaminoglycan (GAG) chains attached within proteoglycans.
The variability of the glycan structures between different species
and between tissues in the same species as well as their exposed
position at the cell surface makes these glycoconjugates excellent
targets for virus attachment [1]. For most viruses that utilize glycan
receptors, the binding is mediated by electrostatic interaction
between the viral attachment protein and negatively charged sialic
acid (SIA)-containing glycan determinants or sulfated portions of
glycosaminoglycans. The virus recognition motif can be spike
glycoproteins displayed on the lipid bilayer of enveloped viruses, or
specific features, such as protrusions or depressions, conformed on
the assembled capsid surface of non-enveloped viruses. The motif
may be composed of a single protein or assembly of several
proteins. The diverse interactions that occur between the viral
pathogen and host, especially the recognition of cell surface
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receptors determines host specificity and tissue tropism. The
pathway of entry into the cell and subsequent interactions
influence the pathogenic outcome of infection.
Many members of the Parvoviridae family, single-stranded DNA
containing non-enveloped icosahedral viruses, utilize glycans for
attachment or/and cellular entry. Bovine adeno-associated virus
and human parvovirus B19 use gangliosides, adeno-associated
virus serotype 1 (AAV1), AAV4, AAV5, AAV6, bovine parvovirus,
H-1 parvovirus, porcine parvovirus, and minute virus of mice
(MVM) use SIA, AAV2 and AAV3b use heparan sulfate
proteoglycan, and AAV9 utilizes terminal galactose as a receptor
[2–20]. Sialic acid commonly occurs at the non-reducing termini
of glycans linked within glycoconjugates and comprises a family of
structurally diverse monosaccharides derived from neuraminic
acid, a nine-carbon sugar. More than 50 natural analogues result
from modifications to the SIA backbone [21]. In general, the C-5
position is either N-acetylated (N-acetylneuraminic acid; Neu5Ac),
N-glycolylated (N-glycolylneuraminic acid; Neu5Gc) or hydroxyl-
ated (deaminoneuraminic acid; KDN). The hydroxyl groups on
SIA can be free, esterified (acetylated, lactoylated, sulfated,
phosphorylated), or etherified (methylated), leading to increased
chemical diversity [22].
Two strains of MVM, the prototype strain (MVMp) and the
immunosuppressive strain (MVMi), serve as models for under-
standing the role of parvovirus capsid-SIA receptor interaction in
infection. Previous studies, in which pretreatment of fibroblasts
with neuraminidase or proteinase K abolished MVM infection
showed that SIA-containing glycoprotein(s) are required for
cellular recognition [7,23]. This requirement was further con-
firmed by glycan microarray screening [24]. Nam et al. [24]
showed that both MVM viruses specifically recognize a2-3
sialylated glycans with a type-2 Galb1-4GlcNAc motif (39SIA-
LN) and a Lewis X Galb1-4(Fuca1-3)GlcNAc motif (39SIA-Lex)
with MVMi showing expanded recognition of multisialylated
glycans with terminal a2-8 linkages. The two viruses share 97%
sequence identity in the capsid viral protein (VP) amino acid
sequence and are serologically indistinguishable. MVMp was
originally isolated from a murine adenovirus stock and replicates
efficiently in mouse fibroblasts such as the A9 cell line, whereas
MVMi, which was recovered from an EL4 T-cell lymphoma,
replicates in mouse T lymphocytes and hematopoietic precursors
[25]. The viruses are reciprocally restricted for growth in each
other’s cell type. Cell binding assays show that both strains bind to
and enter the restricted cell, but there is a block prior to replicative
form DNA replication likely due to a block in uncoating which is
dictated by the VP sequence [26–28]. Both viruses are however
oncotropic and display oncolytic activity in vitro, and are both able
to infect the transformed human cell line NB324K (SV40
transformed human newborn kidney fibroblast cells), suggesting
that the restricting environment is eliminated in tumor cells. In vivo,
following intranasal inoculation into newborn mice, MVMi is
pathogenic and replicates in endothelia, neuroblasts [29], and
hematopoietic stem cells. In adult Severe Combined Immunode-
ficient (SCID) mice MVMi causes acute leucopenia [30], while
MVMp infection is asymptomatic [31]. The 39SIA-LeX motif, a
known tumor cell marker [32,33], has been proposed as the
mediator of transformed cell recognition by the MVM viruses and
the interaction with the multisialylated a2-8 glycans, found in
brain glycoproteins [34], the mediator of MVMi’s neurotropism.
In this study, MVMp and MVMi were screened on a sialylated
glycan microarray (SGM) containing terminal SIA structures
presented on type-1 (Galb1-3GlcNAcb1-R) and type-2 (Galb1-
4GlcNAcb1-R) glycan precursors to determine (I) if they recognize
SIAs with different modifications and (II) if there is a difference in
the SIA recognition and affinity by MVM capsids with a packaged
genome (virions), empty (no DNA) capsids, and virus-like particles
(VLPs) containing only their major capsid protein, VP2. All the
viruses bound to glycans with the 9-O-methyl SIA derivative with
the MVMp viruses showing additional recognition of 9-O-acetyl
and 9-O-lactoyl SIA derivatives. Both MVM strains also
recognized biantennary glycans with terminal 39SIA-LN motifs.
The data verified that the surface properties of VLPs are
indistinguishable from those of wild type empty capsids and
virions, and validates their use in lieu of infectious virions to study
MVM interactions with host cell surface glycan receptors. Glycan
profiling of cells reciprocally restrictive for MVMi and MVMp (A9
fibroblasts and EL4 T lymphocytes, respectively) or permissive for
both viruses (NB324K), identified glycan compositions consistent
with those recognized by the MVM capsids in the SGM and
previous glycan microarrays [24,35]. These observations indicate
a potential role for the glycans identified by these solid-phase
binding assays in cellular infection by the MVM viruses.
Materials and Methods
Cell Lines
A9ouabr11 cells are a ouabain-resistant derivative of the
HGPRT2 L mouse fibroblast cell line A9 that are permissive
host cells for MVMp [36]. EL4 T cells are a strain of the mouse T-
cell lymphoma that are permissive for MVMi [36]. NB324K is a
clone of simian virus-40 transformed human newborn kidney
fibroblast cells that is permissive for both MVMp and MVMi [36].
Glycomic profiling was performed with 16107 cells of each
mammalian cell line, which were cultured in Dulbecco’s modified
Eagle medium (DMEM) supplemented with 5% heat-inactivated
fetal bovine calf serum.
Glycan Profiling
The cells were scraped into the medium and harvested by
centrifugation at 2506g for 5 min. Cells were washed three times
with 1X phosphate-buffered saline (PBS, Invitrogen, Carlsbad,
CA), pelleted, resuspended in 1 ml of PBS, transferred to a
microfuge tube, and pelleted at 8006g. The supernatant was
aspirated, and the cell pellet was stored at 280uC. Further
processing of the cell lines to derivatize, extract, purify, and
analyze the glycans by mass spectrometry was carried out as
described by North et al. [37].
Generation of Full (MVM-Full) and Empty MVM (MVM-
Empty) Capsids
A9 ouabr11 cells were grown in spinner culture in DMEM
containing 5% fetal bovine serum and antibiotics to a density of
,66105 cells/ml. The cultures were infected with predetermined
titers of transfection-derived parvovirus MVMp stocks and
expanded until cell counts indicated a progressive rise in numbers
of dead cells. The cells were harvested by centrifugation, washed in
PBS without Ca2+or Mg2+, pelleted, and resuspended in 10 ml of
TE8.7 (50 mM Tris-HCl pH 8.7, 0.5 mM EDTA) per liter of
infected cells. Following three cycles of freeze-thaw at 37uC the
samples were centrifuged repeatedly at 8006g to clarify the
supernatant and were stored at 220uC.
For virus purification, 6-ml supernatant aliquots were further
clarified by centrifugation at 14,4626g in a Sorvall SS34 rotor at
4uC and then floated on top of a 6-ml iodixanol (OptiPrep; Axis-
Shield, Oslo, Norway) step gradient (1 ml 55% and 2 ml 45% in
PBS plus 1 mM MgCl2 and 2.5 mM KCl, followed by 2 ml 35%
and 1 ml 15% in TE8.7). Samples were centrifuged at 209,4916g
for 18 h at 18uC in a Beckman SW41 rotor. Fractions were
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collected from the bottom of the gradient and full and empty
capsid concentrations were assessed by hemagglutination and
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE). The capsid integrity was checked by negative-stain
electron microscopy (EM). For the EM, 5 ml of purified virus at
an estimated concentration of 2.0 mg/ml was spotted onto a 400
mesh carbon-coated copper grid (Ted Pella, Inc., Redding, CA,
USA) for 1 min before blotting with filter paper (Whatman No.5).
The sample was then negatively stained twice with NanoW
(Nanoprobe) for 1 min, blotted dry, and viewed on a Hitachi 3000
electron microscope. MVMi (full and empty) capsids were
produced in the same way as MVMp except that the transfection
utilized NB324K cells. For SGM screening, all viruses were buffer-
exchanged into 1XPBS and the concentrations adjusted to
0.5 mg/ml using Ultrafree 150 kDa cut-off centrifugal filter units
(Millipore, Billerica, MA).
Recombinant Virus Production and Purification
Recombinant baculovirus constructs expressing the VP2 of wt
MVMi and MVMp that self-assemble into VLPs (MVMp-VLP
and MVMi-VLP) were constructed as described [38]. Sf9 insect
cells growing in suspension culture in Erlenmeyer flasks in Sf-900
II SFM media (Gibco/Invitrogen Corporation) at 27uC were
infected with a titered baculovirus construct at a multiplicity of
infection of 5.0 plaque-forming units per cell. Following incuba-
tion at 27uC for ,70 h, the cells were spun down at 1,5886g for
15 min in a JA-10 rotor and then the pellet resuspended in lysis
buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 0.2% Triton X-
100, 10 mM MgCl2). The MVMp and MVMi VLPs were purified
based on published procedures with some modifications [38]. The
VLPs were released from the cells by three cycles of rapid freeze-
thaw with the addition of Benzonase (Merck KGaA, Germany)
after the second cycle. The cellular debris was removed by low
speed centrifugation at 12,0646g, 15 min, and 4uC in a JA-20
rotor. The supernatant was diluted with TNET buffer (50 mM
Tris-HCl pH 8.0, 100 mM NaCl, 1 mM EDTA, 0.2% Triton X-
100) and pelleted through a 20% (w/v) sucrose cushion by
ultracentrifugation at 207,8716g for 3 h at 4uC in a 70Ti rotor.
The resulting pellet was resuspended overnight at 4uC in TNTM
buffer (25 mM Tris-HCl pH 8.0, 100 mM NaCl, 0.2% Triton X-
100, and 2 mM MgCl2). The resuspended sample was then
subjected to a low-speed spin at 8006g for 2 min to remove
particulate material and further purified by ultracentrifugation on
a sucrose-step gradient (5–40% w/v in TNTM) at 209,4916g for
3 h at 4uC in a Beckman SW41Ti rotor. A visible blue fraction
containing VLPs, sedimenting at ,20–25% sucrose, was extracted
with a syringe and needle, and dialyzed against TE buffer (25 mM
Tris-HCl pH7.5, 1 mM EDTA). Next, CsCl was added to the
dialyzed sample to a final density of 1.31 g/cm3 and then
subjected to equilibrium centrifugation at 209,4916g for 24 h at
4uC in a Beckman SW41Ti rotor. Visible virus fractions were
extracted with a syringe and needle, and extensively dialyzed into
1XPBS. The concentration of the viruses was estimated from
optical density measurements (assuming an extinction coefficient
of 1.0 for MVM VLPs) and adjusted to 0.5 mg/ml using Ultrafree
150 kDa cut-off centrifugal filter units (Millipore, Billerica, MA).
The purity and integrity of the viral capsids were monitored using
SDS–PAGE gel electrophoresis and negative-stain EM, respec-
tively, as described above.
Preparation of SGM (Sialylated Glycan Microarray) and
Virus Screening
Terminally sialylated glycans with various SIA modifications
were synthesized as previously described [39,40]. Seventy-seven
sialylated structures were generated incorporating 16 different
terminal SIAs on 4 different underlying structures that were tagged
with a fluorescent linker (Table S1). Each glycan was quantified
based on its fluorescence and printed on NHS-activated glass slides
in replicates of n= 4 to generate the SGM. The printed slides were
washed and blocked with 50 mM ethanolamine in 0.1 M Tris-
HCl buffer (pH 9.0) for 1 h, and prior to screening the slides were
rehydrated for 5 minutes in TSM buffer (20 mM Tris-HCl,
150 mM NaCl, 0.2 mM CaCl2, and 0.2 mM MgCl2). The virus
samples were diluted with Binding Buffer (TSM buffer plus 1%
BSA and 0.05% Tween 20) to give a final volume of 70–100 ml
(0.05 mg/ml), which was added to the slide and incubated at RT
for 1 h. The slides were then washed with Wash Buffer (TSM
buffer plus 0.05% Tween 20), and an anti-MVM capsid antibody
(Tatt-2; polyclonal from rabbit) was added at a dilution of 1:5,000.
The slides were washed again with Wash buffer and incubated
with Cy5-labeled-goat anti-rabbit IgG at 5 mg/ml. The slides were
scanned with a Perkin Elmer ProScanarray microarray scanner
equipped with 4 lasers and for Cy5 fluorescence, the wavelengths
649 nm (Excitation) and 670 nm (Emission) were used. The
scanned images were analyzed with the ScanArray Express
software to determine the average relative fluorescence units
(RFU) and standard deviation (S.D) of the four replicates. In the
output plot, the y-axis represents the average RFU and the x-axis
represents 77 sialylated glycans and seven controls (LNnT, NA2,
Man5, LNT, lactose, fetuin, and biotin, see abbreviations below),
corresponding to chart ID 1–84. To analyze the results, all glycans
were ranked according to their signal-to-noise (S/N) ratio by
dividing the mean RFU from four replicates by the mean
background generated in the control wells lacking sialylated
glycans. Variation within the 4 replicates was assessed as the
coefficient of variation (%CV), which was calculated as 100 6
S.D/Mean. Any value with a %CV of .30, was considered
unacceptable as reported in Song et al. [40].
Abbreviations: LNnT = Galb1-4GlcNAcb1-3Galb1-4Glc; LNT
[Galb1-3GlcNAcb1-3Galb1-4Glc]; NA2 = Galb1-4GlcNAcb1-
2Mana1-6(Galb1-4GlcNAcb1-2Mana1-3)Manb1-4GlcNAcb1-
4GlcNAc; Man5 = Mana1-6(Mana1-3)Mana1-6(Mana1-
3)Manb1-4GlcNAcb1-4GlcNAc.
Results
Virus Purification
The purity and integrity of the MVM capsids used in this study
(MVMp-Full, MVMp-Empty, MVMp-VLP, MVMi-Full, MVMi-
Empty, and MVMi-VLP) were verified by SDS-PAGE and
negative-stain EM (Figure 1), prior to SGM screening. The
SDS-PAGE analysis showed that the full capsids contained VP1
(83 kDa), VP2 (64 kDa), and VP3 (61 kDa); empty capsids
contained VP1 and VP2; and all the VLPs contained only VP2.
The negative stain EM analysis showed the full and empty capsids
and VLPs to be intact.
Recognition of Sialyl Derivatives by MVM Viruses on the
SGM
Three types of MVMp and MVMi capsids; VLPs, empty, and
full capsids, were screened on the SGM. For each particular strain,
MVMp or MVMi, the binding profile was similar for the VLPs,
empty, and full capsids (Figure 2). The SGM had both a2-3 and
a2-6 linked sialylated glycans and 7 asialoglycans as controls, but
MVMp and MVMi specifically bound only to the a2-3 linked
sialylated derivatives (Figure 2 and 3; Supplemental Tables S2, S3,
and S4). MVMp and MVMi showed a preference for binding to
SIA that was methylated at C-9 and not C-8. Out of a total of 4
MVM Glycan Interactions
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glycans that were derivatized with Neu5Ac9-O-methyl sialic acid,
MVMp and MVMi bound only to two glycans, SGM 23
(Neu5Ac9Mea2-3Galb1-4GlcNAcb1-3Galb1-4Glcitol) and SGM
55 (Neu5Ac9Mea2-3Galb1-4GlcNAcb1-2Mana1-3(Galb1-
4GlcNAcb1-2 Mana1-6)Manb1-4GlcNAcb1-4GlcNAcitol), where
the methylated sialic acid was a2-3 linked. The other two glycans
with SIA that were methylated at C-9, SGM 8 (Neu5Ac9Mea2-
6Galb1-4GlcNAcb1-3Galb1-4Glcitol) and SGM 40 (Neu5Ac9-
Mea2-6Galb1-4GlcNAcb1-2Mana1-3(Galb1-4GlcNAcb1-2Ma-
na1-6)Manb1-4GlcNAcb1-4GlcNAcitol) are similar to SGM 23
and SGM 55, respectively, but the sialic acid is a2-6 linked and
not recognized by the MVM viruses. In addition, all the MVM
viruses bound to the biantennary glycan, SGM 48 (Neu5Aca2-
3Galb1-4GlcNAcb1-2Mana1-3(Neu5Aca2-3Galb1-4GlcNAcb1-
2Mana1-6)Manb1-4GlcNAcb1-4GlcNAcitol) on the SGM.
All the MVMp viruses showed weak binding to two additional
glycans that were not recognized by the MVMi viruses. The first
was a biantennary glycan having Neu5,9Ac2 (9-O-acetylated SIA)
where the sialic acid was linked a2-3 to the terminal Gal of type-2
glycan (SGM 52: Neu5,9Ac2a2-3Galb1-4GlcNAcb1-2Mana1-
3(Galb1-4GlcNAcb1-2Mana1-6)Manb1-4GlcNAcb1-4GlcNAci-
tol). The second glycan had Neu5Ac9Lt (9-O-lactoylated SIA)
where the sialic acid was linked a2-3 to the terminal Gal of type-2
glycan (SGM 60: Neu5Ac9Lta2-3Galb1-4GlcNAcb1-2Mana1-
3(Neu5Ac9Lta2-3Galb1-4GlcNAcb1-2Mana1-6)Manb1-
4GlcNAcb1-4GlcNAcitol). The binding profile for the genome
containing viruses, especially MVMp virions, showed some weak
non-specific binding, with high %CV, to other glycans compared
to the VLPs and empty capsids (Figure 3). The affinity ranking of
the derivatized glycans recognized by MVMp was in the order 9-
O-methylated-monosialylated (SGM 23) .9-O-methylated-bian-
tennary (SGM 55) .9-O-acetylated-biantennary (SGM 52) < 9-
O-lactolylated-biantennary (SGM 60) < SIA-biantennary (SGM
48) (Figure 3). The affinity ranking for the MVMi viruses was 9-O-
methylated-monosialylated (SGM 23) .9-O-methylated-bian-
tennary (SGM 55).SIA-biantennary (SGM 48). All these glycans
had type-2 LacNAc (Galb1-4GlcNAcb1-R) as the core structure
and were derived from either LNnT or NA2 precursor glycans.
Figure 1. Virus purification. Coomassie stained SDS-PAGE for MVMp-VLP (a.1), MVMp-Empty (b.1), MVMp-Full (c.1), MVMi-VLP (d.1), MVMi-Empty
(e.1), MVMi-Full (f.1). The positions of low-molecular-weight (LMW) standards (in kDa; Bio-Rad, Hercules, CA, USA) are indicated on the left-hand side.
Negatively stained electron micrographs are shown in (a.2), (b.2), (c.2), (d.2), (e.2), and (f.2) respectively. Images in (b.2) and (c.2) were collected at
60,000X magnification while images in (a.2), (d.2), (e.2), and (f.2) were collected at 100,000X magnification.
doi:10.1371/journal.pone.0086909.g001
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Consistent with the previous glycan array screening studies, none
of the MVM viruses bound to the Neu5Gc or KDN sialylated
derivatives [24,35]. Notably, the SGM hits for three of the samples
tested, MVMp-Empty, MVMp-VLP, and MVMi-VLP, were
reproducible in a repeated screening (data not shown). The other
samples were not re-screened due to limited availability.
Glycan Profiling of Cell Lines Permissive/Restrictive for
the MVM Viruses Validate Glycan Screening Data
Three cell lines, A9 fibroblasts (permissive for MVMp), EL4 T
lymphocytes (permissive for MVMi), and NB324K transformed
cells (permissive for both MVMp and MVMi) were subjected to
glycomic profiling by MALDI-MS and MALDI-MS/MS analysis
(http://www.functionalglycomics.org/glycomics/common/jsp/
samples/searchSample.
jsp?templateKey = 2&12 = CellType&operation = refine). The
profiling provided information on the carbohydrate composition
of the glycans present on these cells (Figures 4, 5, 6, and 7), but full
linkages (a2-3SIA or a2-6SIA) present in the glycans was not
determined. However, SIA-SIA (multisialylated) glycans can only
be linked a2-8 or a2-9 to each other. Of the two derivatives of
SIA, Neu5Ac is the major SIA in these cell lines, but Neu5Gc is
present in trace amounts in the N-glycan fraction for A9 and EL4
T cells, and in the glycolipid fraction for the A9 and NB324K cells
(enclosed in dashed black box in Figure 4A and B; Figure 5A; and
Figure 6A and C). The single sialylated O-glycan observed in the
NB324K cells had Neu5Ac (enclosed in green box in Figure 7C).
The mass spectra obtained from the peptide N-glycosidase F-
released and permethylated N-glycans from these cell lines are
shown in Figure 4 and 5. The N-glycans from all three cell lines
showed a full complement of oligomannose as well as complex
type N-glycans with bi-, tri-, or tetra-antennary structures. Hybrid
N-glycans were not observed. The N-glycans on these cell lines
terminated in Man, Gal, GlcNAc, or SIA. Structures consistent
with presence of bisecting GlcNAc in complex N-glycans was also
observed for all three cell lines. All the three cell lines also
possessed core-fucosylated sialoglycans with the A9 cells showing
the least expression of these glycans. In the NB324K cells only, a
structure with a fucose linked to GlcNAc in the antennae, most
likely as part of the 39SIA-Lex motif (Neu5Aca2-3Galb1-4(Fuca1-
3)GlcNAcb) is observed (e.g., m/z = 3142.4, m/z = 3952.3, etc.;
enclosed in red box in Figure 4C and 5C, respectively). The N-
glycan composition for the A9 and EL4 T cells were very similar
for the low molecular mass (Figure 4A and B), but for the medium
mass there was more variation (Figure 5A and B). The NB324K
cell line expresses more multi-antennary, poly lacNAc extended
glycans than A9 and EL4 T cells (Figure 5C).
The profiles for the polar glycolipids are shown in Figure 6. For
ease of identification, the common names (if known) of the
identified glycolipids are included in Figure 6. The glycolipids
present in the spectra are consistent with; GM3 (m/z = 855.5),
GM2 (m/z = 1100.7), GM1a (m/z = 1304.9, major species),
GM1b (m/z = 1304.9, minor species), GT3 (m/z = 1577.8),
GD1a (m/z = 1665.9, major species), GD1c (m/z = 1665.9, minor
species), GT1c/GT1a (m/z = 2027.0), and GQc/b (m/z = 2387.1)
[41]. All the glycolipids were identified to be gangliosides
(GalNAcb1-4Galb1-4GlcbCeramide motif). The multisialylated
glycans (linked a2-8 or a2-9) are present in the polar glycolipid
fraction for all the three cell lines. The ganglioside GT3,
recognized by MVMi in a previous glycan array screening, was
present only on A9 cells, at low abundance (enclosed in green box
in Figure 6A) [24]. However, the core motif in GT3 (Neu5Aca-
Neu5Aca-Neu5Aca-Gal-Glc) is also present in the GT1c that is
expressed in EL4 T cells albeit also at low abundance (enclosed in
blue box in Figure 6A and B). Branching of glycans was observed
for the polar glycolipid fraction.
The mass spectra of the permethylated O-glycans from the
three cell lines are shown in Figure 7. The ability to produce high
quality O-glycan data after initial removal of N-glycans can be
limited by low cell numbers. However, the A9 and EL4 T cells
were shown to express a core 1 O-glycan, whilst the NB324K cells
express both core 1 and core 2 O-glycans. The glycan that is
expressed in all the three cell lines at the highest abundance (m/
z = 534.5; enclosed in red box in Figure 7A–C) can be classified as
T antigen and belongs to core 1 O-glycan (Galb1-3GalNAcaSer/
Figure 2. Sialylated derivatives recognized by the MVM viruses. The glycan number and the schematic representation are shown.
doi:10.1371/journal.pone.0086909.g002
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Thr) [42]. The only SIA containing O-glycan (green box in
Figure 7C) is expressed on the NB324K cells and belongs to core
1. The remaining O-glycans expressed on the NB324K cells
belong to core 2 (GlcNAcb1-6(Galb1-3)GalNAcaSer/Thr) (m/
z = 779.4, m/z = 983.6).
Discussion
MVM Binds to Diverse Sialylated Derivatives
Glycan arrays attempt to mimic the diversity of glycans present
on cell surfaces, and if a virus specifically recognizes a particular
type of glycan on these arrays, it suggests that the virus may also
recognize similar glycans in its natural host. The SGM binding
profile for the three types of MVMp and MVMi capsids tested,
VLPs, empty, and full capsids, were strain dependent (Figure 2
and 3). The recognition of similar glycans by full and empty
capsids of each particular strain indicates that the encapsidation of
DNA by the full capsids followed by its maturation, i.e. cleavage of
VP2 to give VP3 [43], does not affect its receptor binding ability
compared to empty capsids, consistent with previous observations.
In addition, the similar recognition profile for empty capsids and
Figure 3. SGM array data for the MVM capsids. (A) MVMp-Full, (B) MVMp-Empty, (C) MVMp-VLP, (D) MVMi-Full, (E) MVMi-Empty, and (F) MVMi-
VLP. The bars represent relative fluorescence for a given glycan. The glycans showing specificity to the MVM viruses are labeled.
doi:10.1371/journal.pone.0086909.g003
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VLPs supports the previous observations that they are antigeni-
cally and structurally equivalent [38,44,45].
The MVMp or MVMi viruses exhibited a specific preference
for Neu5Aca2-3 glycans and did not bind to Neu5Gc or its
derivatives even though it exists in mammals, and other
parvoviruses such as AAV5 and CPV have been reported to
recognize SIA glycans with this modification ([46,47], and
unpublished data). Also, none of the KDN derivatives were
recognized, further confirming that the N-acetyl group at C-5 is
preferred. The N-acetyl group at C-5 is within interaction distance
of the side-chain of D399 and backbone of E400 in the MVM VP2
sequence. D399 has been shown to be an important determinant
of SIA recognition by MVM and tissue tropism [23,48].
The MVMp and MVMi viruses showed stronger binding to a2-
3 SIA that is methylated at position C-9 of Neu5Ac (SGM 23 and
SGM 55), compared to the other derivatives (acetylated or
lactoylated Neu5Ac, such as SGM 52 and SGM 60, respectively,
or Neu5Gc) and also non-derivatized Neu5Ac glycan (SGM 48) in
the SGM (Figure 3). In addition, this hydrophobic methyl group is
specifically preferred at position C-9 and not at C-8. This novel
recognition is interesting, but its potential role in MVM infection is
not known because this is a synthetic derivative that has not yet
been observed in nature. Also, docking of a 3D model of a SIA
Figure 4. MALDI-TOF MS profiles of the permethylated low mass N-glycans. Low mass N-linked glycan expression on (A) A9 cells, (B) EL4 T
cells, and (C) NB324K cells is shown. The glycans are annotated in the cartoon form. Inset depicts the cartoon legend.
doi:10.1371/journal.pone.0086909.g004
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glycan methylated at C-9 or C-8 of the glycerol side group into the
MVMp SIA binding site localized to the icosahedral 2-fold region
[23] did not provide any clues to this differential specificity (data
not shown). The C-8 or C-9 of Neu5Ac in the MVMp-VLP-SIA
complex structure is not in close proximity to any capsid surface
amino acid residues that might affect the glycan binding
interaction because the glycerol group points outward from the
binding pocket (data not shown). MVMp and MVMi bound to the
only Neu5Aca2-3 non-derivatized biantennary glycan on the
SGM (SGM 48, Table S1). Thus while the signal was weak
compared to the Neu5Ac methylated derivatives, recognition of
SGM 48 suggests a strong preference for its structure which is
consistent with the previous glycan array screenings [24,35].
Significantly, this is consistent with the structures (based only on
composition) observed in the cells that are permissive to MVM
infections as determined by glycan profiling (Figure 4).
The MVMp viruses, but not MVMi viruses, bound to the 9-O-
acetylated Neu5Ac derivative (SGM 52) (Figure 2, and Figure 3A,
B and C). Significantly, SIA 9-O-acetylation is up-regulated (e.g.,
9-O-acetylated GD3) in human melanoma cells [49]. The
enveloped viruses bovine coronavirus (BCoV) and influenza c
virus require 9-O-acetylated SIA containing receptor for a
successful infection. These viruses possess an 9-O-acetyl esterase
activity that promotes escape of virion progeny [50]. Thus it is
possible that MVMp can also recognize and utilize this SIA
derivative for the infection of cancer cells. The MVMp viruses also
bound to the 9-O-lactoylated Neu5Ac derivative (SGM 60), which
are present in serum glycoproteins [51]. A role for this interaction
in MVMp infection is not obvious at this time. These additional
MVMp interactions suggest that the surface properties of the
MVMp capsid allows for the binding of SIA derivatives that are
not recognized by the MVMi capsid and that the type of
Figure 5. MALDI-TOF MS profiles of the permethylated medium mass N-glycans. Medium mass N-linked glycan expression on (A) A9 cells,
(B) EL4 T cells, and (C) NB324K cells is shown. The glycans are annotated in the cartoon form. Inset depicts the cartoon legend.
doi:10.1371/journal.pone.0086909.g005
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substitutions at position C-9 of the SIA dictated this extended
recognition. However, despite the clustering of MVMp/MVMi
amino acid differences at the 2-fold axis of the capsid [44] and
based on the MVM-SIA complex structures currently available
([23], and unpublished data), the C-9 position of SIA derivatives is
not involved in any capsid interactions, as discussed above. Thus a
potential role for these recognition differences in dictating the
MVMp and MVMi tissue tropism is not immediately evident and
requires further study.
Previous glycan array screening studies had focused on
identifying the oligosaccharide motif(s) recognized by MVM
among a large number of different glycans [24] while screening
on the SGM enabled the exploration of differential SIA-MVM
strain recognition. MVM had been shown to bind to glycans with
terminal Neu5Aca2-3 and not Neu5Aca2-6 [24]. The SGM
screen confirmed these previous observations and the diversity of
SIA modifications on this array allowed for detection of novel
MVM glycan interactions, both naturally occurring and synthetic.
In addition, this screen identified, for the first time, the recognition
of biantennary glycans with terminal 39SIA-LN motifs.
Figure 6. MALDI-TOF MS profiles of polar glycolipids. (A) A9 cells, (B) EL4 T cells, and (C) NB324K cells. The glycans are annotated in the
cartoon form. The glycolipids were deutero-reduced (DR) to differentiate between symmetrical molecules in subsequent MS/MS analyses. M and m
refer to major and minor species, respectively. Inset depicts the cartoon legend.
doi:10.1371/journal.pone.0086909.g006
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Cellular Glycan Profiling Parallels Glycan Array Screening
Data
The SIA (a2-3 or a2-6) and the LacNAc linkage information
were not determined in the glycan profiling experiment. The
glycan motifs recognized by MVM viruses in previous glycan
arrays [24,35] and current SGM (Figure 2), for example, SIA-LN
(green or blue box in Figure 5A, B, and C), SIA-Lex (red box in
Figure 4C and 5C), and SIA-SIA-SIA (GT3, green box in
Figure 6A), are also expressed on the three cell types profiled. In
addition, the biantennary complex N-glycan, SGM 48, which was
recognized by both viruses in the SGM array, is present in the low
mass fraction of A9 cells and NB324K cells (m/z = 2792.2,
enclosed in dashed red box in Figure 4A and C). The glycan SIA-
LN-LN motif that was recognized in previous glycan array
screening is possibly (based on the linkage combinations allowed)
present in the NB324K medium mass N-glycan fraction (m/
z = 4850.2) (enclosed in a dashed green box in Figure 5C). As with
the SGM, the three cell lines displayed a variety of carbohydrates,
including Neu5Ac, Neu5Gc, and non-sialylated glycans. This
observation thus validates the use of such arrays to identify
potential binding partners for macromolecules, including viruses.
The polar glycolipid fractions of A9 and EL4 T cells, but not
their N- and O-glycan fractions, showed the presence of a2-8
multisialylated glycans, such as GT3 which were recognized by
MVMi viruses, but not MVMp, in a previous glycan array
screening [24]. The restricted infection of A9 cells by MVMi is
thus likely not controlled by this glycan interaction. Previous
experiments have shown that a SIA containing glycoprotein (and
not glycolipid) is utilized as a receptor for MVM infection [7,23],
but the glycan array utilized by Nam et al. [24] did not
differentiate the origin of the GT3. Several recent studies have
shown that a2-8 multisialylated glycans, especially GT3 and GD3,
are present on glycoproteins in the mouse brain [34,52–54]. Thus
it is possible that MVMi viruses utilize an a2-8 multisialylated
glycoprotein for infection in neuronal cells. Multisialylated
glycoproteins with a2-8 linkages, such as Neural Cell Adhesion
Molecule (NCAM), MCAM (melanoma cell adhesion molecule),
and CD166 (or Activated Leukocyte Cell Adhesion Molecule
(ALCAM)), are commonly found expressed on the neuronal cells
and could serve as receptors for MVMi on these cells [53,55]. A
profiling of a mouse derived neuronal cell line would aid in
validating the abundance of and the possibility that MVMi utilizes
a2-8 linked glycans for neuronal cell infection.
The NB324K cell line is a transformed cell line that expresses
sialylated N-glycans with the SIA-Lex motif (e.g., m/z = 3142.4,
m/z = 3952.3, etc.; enclosed in red box in Figure 4C and 5C,
respectively) which is a known carbohydrate marker for cancer
cells [32,33,56,57]. The expression of this motif has also been
specifically observed in the N-glycan profile of other transformed
cell lines such as THP-1 (monocytic leukemia cell line), HL-60
(promyelocytic leukemia cells), and K562 (erythromyeloblastoid
leukemia cell line) (http://www.functionalglycomics.org/
glycomics/publicdata/glycoprofiling-new.jsp). This motif was
recognized previously by the MVM viruses on a glycan array
[24]. This supports the suggestion that the SIA-Lex motif on tumor
cell lines might be utilized by the oncotropic MVM viruses for
infection.
The A9 and EL4 T cells have a similar glycan profile and an
abundance of sialylated glycans recognized by the two viruses in
glycan arrays. This similarity in glycan profile thus fails to explain
the differences in tropism for these cells between these MVM
viruses based on differential cell surface glycan receptor recogni-
tion. These observations support previous claims that the
determinant of differential cell and tissue tropism for MVMp
and MVMi is post cell entry [26,28,36,58,59]. These previous
reports identified amino acids at and surrounding the depression at
icosahedral 2-fold axes of the capsid, which differ between the
viruses, as playing a crucial role in dictating these differences. The
site reported for the MVMp-SIA interaction is a pocket flanking
the 2-fold axis [23]. The observed similarity in glycan recognition
by the two viruses suggests that the critical glycan interacting
residue(s) is conserved. It is possible to envisage a scenario in
which, following the initial capsid interaction with a cell surface
glycan, an MVM strain specific interaction with a cellular host
factor present only in the permissive cell line, initiates downstream
events required for infection. These post entry interactions could
Figure 7. MALDI-TOF MS profiles of the O-glycans. (A) A9 cells,
(B) EL4 T cells, and (C) NB324K cells. The glycans are annotated in the
cartoon form. Inset depicts the cartoon legend.
doi:10.1371/journal.pone.0086909.g007
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also be under the control of similar glycan(s) on host cell specific
glycoprotein receptors yet to be identified. These possibilities
remain to be verified.
Summary
For the MVM viruses, both modifications of SIA and their
linkage to core structures regulate recognition. The binding profile
for VLPs, empty, and full particles was similar on the SGM which
validates the use of VLPs in lieu of infectious virions for structural
and biochemical studies that examine receptor interactions. Future
directions include structural studies of the MVM virus complexed
with the glycans identified in microarrays to elucidate the capsid-
receptor interactions that likely dictate the similarities and
differences observed for MVMp and MVMi. The glycomic
profiling data correlates with the glycans that were recognized
by the MVM viruses in a previous glycan screening and those
identified in the current SGM, such as glycans with SIA-LN motif,
SIA-Lex motif, the a2,8 multisialylated glycans, and the biantenn-
ary glycans. The abundance and variability of SIA containing
glycans on these cell surfaces, makes them suitable receptors for
numerous interactions, as exemplified by the large number of
viruses, such as MVM, for which this interaction is essential for
infection.
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